The impact of empagliflozin on obstructive sleep apnea and cardiovascular and renal outcomes: An exploratory analysis of the empa-reg outcome trial. diabetes care 2020;43:3007–3015

Neeland, I. J., Kasai, T., Inzucchi, S. E., Wojeck, B. S., Yaggi, H. K., & Johansen, O. E. (2021). The impact of empagliflozin on obstructive sleep apnea and cardiovascular and renal outcomes: An exploratory analysis of the empa-reg outcome trial. diabetes care 2020;43:3007–3015. Diabetes Care. American Diabetes Association Inc. https://doi.org/10.2337/dci21-0009